Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
申请人:OSI Pharmaceuticals, Inc.
公开号:EP1731520A1
公开(公告)日:2006-12-13
This invention pertains to pyrrolo [2,3-d] pyramidine derivated compounds which specifically inhibit the adenosine A1, A2A and A3 receptors and the use of these compounds to treat a disease associated with A1, A2A and A3 adenosine receptors in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
本发明涉及专门抑制腺苷 A1、A2A 和 A3 受体的吡咯并[2,3-d]吡脒衍生物化合物,以及使用这些化合物治疗受试者体内与腺苷 A1、A2A 和 A3 受体相关的疾病,包括给受试者施用治疗有效量的化合物。